Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
13.23
-0.34 (-2.51%)
At close: Dec 5, 2025, 4:00 PM EST
13.24
+0.01 (0.08%)
After-hours: Dec 5, 2025, 5:01 PM EST
IART Market Cap
IART has a market cap or net worth of $1.03 billion as of December 5, 2025. Its market cap has decreased by -41.59% in one year.
Market Cap
1.03B
Enterprise Value
2.77B
1-Year Change
-41.59%
Ranking
Category
Stock Price
$13.23
Market Cap Chart
Since December 1, 1998, IART's market cap has increased from $68.40M to $1.03B, an increase of 1,407.74%. That is a compound annual growth rate of 10.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.03B | -41.07% |
| Dec 31, 2024 | 1.75B | -48.60% |
| Dec 29, 2023 | 3.40B | -27.30% |
| Dec 30, 2022 | 4.68B | -17.47% |
| Dec 31, 2021 | 5.67B | 3.71% |
| Dec 31, 2020 | 5.47B | 9.33% |
| Dec 31, 2019 | 5.00B | 30.27% |
| Dec 31, 2018 | 3.84B | 2.28% |
| Dec 29, 2017 | 3.76B | 17.10% |
| Dec 30, 2016 | 3.21B | 27.95% |
| Dec 31, 2015 | 2.51B | 40.98% |
| Dec 31, 2014 | 1.78B | 32.57% |
| Dec 31, 2013 | 1.34B | 27.26% |
| Dec 31, 2012 | 1.05B | 27.46% |
| Dec 30, 2011 | 826.90M | -38.13% |
| Dec 31, 2010 | 1.34B | 27.27% |
| Dec 31, 2009 | 1.05B | 6.79% |
| Dec 31, 2008 | 983.30M | -11.05% |
| Dec 31, 2007 | 1.11B | -6.54% |
| Dec 29, 2006 | 1.18B | 18.91% |
| Dec 30, 2005 | 994.70M | -6.60% |
| Dec 31, 2004 | 1.07B | 36.87% |
| Dec 31, 2003 | 778.10M | 62.88% |
| Dec 31, 2002 | 477.70M | -29.40% |
| Dec 31, 2001 | 676.60M | 189.39% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |